Study shows how thymoglobulin reduces rejection risk in kidney transplant Telemanagement The two most common antibodies used are thymoglobulin and basiliximab. In a new trial carried out by researchers at Washington University School of Medicine the two antibodies are compared for their ability to reduce rejection of a new kidney. The ... |
